325 related articles for article (PubMed ID: 18325574)
21. Leukotriene receptor antagonists versus inhaled steroids in asthma.
Richardson CR
J Fam Pract; 1999 Jul; 48(7):495-6. PubMed ID: 10428241
[No Abstract] [Full Text] [Related]
22. Intermittent or daily montelukast versus placebo for episodic asthma in children.
Valovirta E; Boza ML; Robertson CF; Verbruggen N; Smugar SS; Nelsen LM; Knorr BA; Reiss TF; Philip G; Gurner DM
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):518-26. PubMed ID: 21624752
[TBL] [Abstract][Full Text] [Related]
23. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
Wilson AM; Orr LC; Sims EJ; Dempsey OJ; Lipworth BJ
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1297-301. PubMed ID: 11029334
[TBL] [Abstract][Full Text] [Related]
24. Montelukast for persistent asthma.
Med Lett Drugs Ther; 1998 Jul; 40(1031):71-3. PubMed ID: 9698701
[No Abstract] [Full Text] [Related]
25. [Leukotriene antagonist added in asthma therapy. Loophole in anti-inflammatory therapy closed].
MMW Fortschr Med; 2003 May; 145(18):56. PubMed ID: 12808826
[No Abstract] [Full Text] [Related]
26. [Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
Zsigmond G; Novák Z; Kósa L
Orv Hetil; 2004 Nov; 145(48):2431-5. PubMed ID: 15638037
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
28. Changes in recommended treatments for mild and moderate asthma.
Redding GJ; Stoloff SW
J Fam Pract; 2004 Sep; 53(9):692-700. PubMed ID: 15353157
[No Abstract] [Full Text] [Related]
29. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
[TBL] [Abstract][Full Text] [Related]
30. Montelukast and Churg-Strauss syndrome.
Hosker HS; Tuggey JM
Thorax; 2001 Mar; 56(3):244. PubMed ID: 11245146
[No Abstract] [Full Text] [Related]
31. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
32. [Leukotriene receptor antagonist effective in chronic asthma].
Jébrak G
Presse Med; 1998 Nov; 27(35):1795. PubMed ID: 9850698
[No Abstract] [Full Text] [Related]
33. Successful outcome of montelukast overdosage in an asthmatic child.
Geller M; Melo LR; Coutinho SV
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):370. PubMed ID: 10752926
[No Abstract] [Full Text] [Related]
34. Budesonide/formoterol (Symbicort) for asthma.
Med Lett Drugs Ther; 2008 Feb; 50(1279):9-11. PubMed ID: 18264031
[No Abstract] [Full Text] [Related]
35. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers.
Wise RA; Bartlett SJ; Brown ED; Castro M; Cohen R; Holbrook JT; Irvin CG; Rand CS; Sockrider MM; Sugar EA;
J Allergy Clin Immunol; 2009 Sep; 124(3):436-44, 444e1-8. PubMed ID: 19632710
[TBL] [Abstract][Full Text] [Related]
36. Adverse events associated with weight-based, high-dose montelukast exposures in children.
Arnold DH; Bowman N; Reiss TF; Hartert TV; Akers WS; Seger DL
Clin Toxicol (Phila); 2020 Feb; 58(2):145-146. PubMed ID: 31056949
[No Abstract] [Full Text] [Related]
37. Childhood asthma. Balancing efficacy and adherence for optimum management.
Sveum RJ
Postgrad Med; 2005 Sep; 118(3):43-50. PubMed ID: 16201308
[TBL] [Abstract][Full Text] [Related]
38. Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.
Knorr B; Nguyen HH; Kearns GL; Villaran C; Boza ML; Reiss TF; Rogers JD; Zhang J; Larson P; Spielberg S
J Clin Pharmacol; 2001 Jun; 41(6):612-9. PubMed ID: 11402629
[TBL] [Abstract][Full Text] [Related]
39. Reports of suicidality in clinical trials of montelukast.
Philip G; Hustad C; Noonan G; Malice MP; Ezekowitz A; Reiss TF; Knorr B
J Allergy Clin Immunol; 2009 Oct; 124(4):691-6.e6. PubMed ID: 19815114
[TBL] [Abstract][Full Text] [Related]
40. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
Bacharier LB; Phillips BR; Zeiger RS; Szefler SJ; Martinez FD; Lemanske RF; Sorkness CA; Bloomberg GR; Morgan WJ; Paul IM; Guilbert T; Krawiec M; Covar R; Larsen G; Mellon M; Moss MH; Chinchilli VM; Taussig LM; Strunk RC;
J Allergy Clin Immunol; 2008 Dec; 122(6):1127-1135.e8. PubMed ID: 18973936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]